Loraine Lie‐A‐Huen

1.4k total citations
34 papers, 1.1k citations indexed

About

Loraine Lie‐A‐Huen is a scholar working on Geriatrics and Gerontology, Emergency Medical Services and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Loraine Lie‐A‐Huen has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Geriatrics and Gerontology, 15 papers in Emergency Medical Services and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Loraine Lie‐A‐Huen's work include Patient Safety and Medication Errors (15 papers), Pharmaceutical Practices and Patient Outcomes (15 papers) and Cardiac, Anesthesia and Surgical Outcomes (9 papers). Loraine Lie‐A‐Huen is often cited by papers focused on Patient Safety and Medication Errors (15 papers), Pharmaceutical Practices and Patient Outcomes (15 papers) and Cardiac, Anesthesia and Surgical Outcomes (9 papers). Loraine Lie‐A‐Huen collaborates with scholars based in Netherlands, United States and Canada. Loraine Lie‐A‐Huen's co-authors include J.Herre Kingma, Maarten J. Suttorp, Marcel G. W. Dijkgraaf, Susanne M. Smorenburg, Joanna E. Klopotowska, Kong I. Lie, E. Gijs Mast, EMILE R. JESSURUN, Norbert M. van Hemel and Paul F. M. Kuks and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and The American Journal of Cardiology.

In The Last Decade

Loraine Lie‐A‐Huen

34 papers receiving 1000 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Loraine Lie‐A‐Huen Netherlands 17 438 315 255 118 100 34 1.1k
Louise Mallet Canada 16 153 0.3× 549 1.7× 81 0.3× 187 1.6× 23 0.2× 58 1.2k
Ricardo J. Gonzalez‐Rothi United States 22 71 0.2× 298 0.9× 240 0.9× 132 1.1× 161 1.6× 32 1.5k
Kyle A. Weant United States 18 167 0.4× 300 1.0× 239 0.9× 119 1.0× 10 0.1× 105 1.1k
Odd Brørs Norway 21 210 0.5× 278 0.9× 83 0.3× 216 1.8× 13 0.1× 64 1.4k
Stephen M. Setter United States 20 141 0.3× 278 0.9× 59 0.2× 72 0.6× 40 0.4× 56 1.6k
Cate Whittlesea United Kingdom 18 54 0.1× 467 1.5× 267 1.0× 161 1.4× 28 0.3× 62 1.3k
Megan A. Rech United States 21 164 0.4× 151 0.5× 93 0.4× 131 1.1× 14 0.1× 130 1.3k
R. Janknegt Netherlands 20 113 0.3× 232 0.7× 55 0.2× 204 1.7× 19 0.2× 80 1.3k
Robin Briant New Zealand 20 203 0.5× 91 0.3× 635 2.5× 56 0.5× 11 0.1× 32 1.4k
Victoria Rollason Switzerland 18 149 0.3× 228 0.7× 33 0.1× 205 1.7× 22 0.2× 50 1.3k

Countries citing papers authored by Loraine Lie‐A‐Huen

Since Specialization
Citations

This map shows the geographic impact of Loraine Lie‐A‐Huen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loraine Lie‐A‐Huen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loraine Lie‐A‐Huen more than expected).

Fields of papers citing papers by Loraine Lie‐A‐Huen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loraine Lie‐A‐Huen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loraine Lie‐A‐Huen. The network helps show where Loraine Lie‐A‐Huen may publish in the future.

Co-authorship network of co-authors of Loraine Lie‐A‐Huen

This figure shows the co-authorship network connecting the top 25 collaborators of Loraine Lie‐A‐Huen. A scholar is included among the top collaborators of Loraine Lie‐A‐Huen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loraine Lie‐A‐Huen. Loraine Lie‐A‐Huen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flint, Robert B., et al.. (2017). Pharmacokinetics of S‐ketamine during prolonged sedation at the pediatric intensive care unit. Pediatric Anesthesia. 27(11). 1098–1107. 13 indexed citations
2.
Boer, Mark de, Maya A. Ramrattan, Jordy J. S. Kiewiet, et al.. (2015). Effect of a ward-based pharmacy team on preventable adverse drug events in surgical patients (SUREPILL study). British journal of surgery. 102(10). 1204–1212. 16 indexed citations
3.
Ramrattan, Maya A., et al.. (2014). Evidence based development of bedside clinical drug rules for surgical patients. International Journal of Clinical Pharmacy. 36(3). 581–588. 5 indexed citations
4.
Ramrattan, Maya A., et al.. (2014). Quality of Pharmaceutical Care in Surgical Patients. PLoS ONE. 9(7). e101573–e101573. 2 indexed citations
5.
Ramrattan, Maya A., et al.. (2013). Adverse drug events in surgical patients: an observational multicentre study. International Journal of Clinical Pharmacy. 35(5). 744–752. 24 indexed citations
6.
Kiewiet, Jordy J. S., Paul F. M. Kuks, W. Mulder, et al.. (2012). Incidence and nature of adverse drug events in surgical patients. European Journal of Hospital Pharmacy. 19(2). 97.2–98. 2 indexed citations
7.
Ramrattan, Maya A., Jordy J. S. Kiewiet, Paul F. M. Kuks, et al.. (2011). Cost-effectiveness of ward-based pharmacy care in surgical patients: protocol of the SUREPILL (Surgery & Pharmacy In Liaison) study. BMC Health Services Research. 11(1). 55–55. 10 indexed citations
8.
Klopotowska, Joanna E., Anne-Cornélie de Pont, Marcel G. W. Dijkgraaf, et al.. (2010). On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study. Critical Care. 14(5). R174–R174. 172 indexed citations
9.
Kemper, E. Marleen, et al.. (2010). Towards evidence‐based pharmacotherapy in children. Pediatric Anesthesia. 21(3). 183–189. 15 indexed citations
10.
Bijleveld, Yuma A., et al.. (2009). Gebruik van procesindicatoren voor kwaliteitsmeting van farmacotherapeutische ouderenzorg bij polyfarmacie. Data Archiving and Networked Services (DANS). 3. 53–56. 1 indexed citations
11.
Wierenga, Peter C., Loraine Lie‐A‐Huen, Evert de Jonge, et al.. (2009). Application of the Bow-Tie Model in Medication Safety Risk Analysis. Drug Safety. 32(8). 663–673. 34 indexed citations
12.
Berg, Leonard H. van den, et al.. (2007). Pharmacokinetics of riluzole: evidence for glucuronidation as a major metabolic pathway not associated with UGT1A1 genotype. Biopharmaceutics & Drug Disposition. 29(3). 139–144. 9 indexed citations
13.
Groeneveld, Geert Jan, et al.. (2007). An Association Study of Riluzole Serum Concentration and Survival and Disease Progression in Patients With ALS. Clinical Pharmacology & Therapeutics. 83(5). 718–722. 21 indexed citations
14.
Deneer, Vera H.M., et al.. (2004). Oral antiarrhythmic drugs in converting recent onset atrial fibrillation. Pharmacy World & Science. 26(2). 66–78. 8 indexed citations
15.
Deneer, Vera H.M., Loraine Lie‐A‐Huen, J.Herre Kingma, et al.. (2004). Absorption kinetics and pharmacodynamics of two oral dosage forms of flecainide in patients with an episode of paroxysmal atrial fibrillation. European Journal of Clinical Pharmacology. 60(10). 693–701. 12 indexed citations
16.
Cox, Eugène, Catherijne A. J. Knibbe, M.W.E. Langemeijer, et al.. (1998). Influence of Different Fat Emulsion-Based Intravenous Formulations on the Pharmacokinetics and Pharmacodynamics of Propofol. Pharmaceutical Research. 15(3). 442–448. 56 indexed citations
17.
Suttorp, Maarten J., J.Herre Kingma, EMILE R. JESSURUN, et al.. (1990). The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Journal of the American College of Cardiology. 16(7). 1722–1727. 203 indexed citations
18.
Suttorp, Maarten J., J.Herre Kingma, Loraine Lie‐A‐Huen, & E. Gijs Mast. (1989). Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. The American Journal of Cardiology. 63(11). 693–696. 136 indexed citations
19.
Lie‐A‐Huen, Loraine, et al.. (1989). High-Performance Liquid Chromatographic Assay of Flecainide and Its Enantiomers in Serum. Therapeutic Drug Monitoring. 11(6). 708–711. 9 indexed citations
20.
Lerk, C. F., et al.. (1979). In Vitro and In Vivo Availability of Hydrophilized Phenytoin from Capsules. Journal of Pharmaceutical Sciences. 68(5). 634–638. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louise Mallet Breakdown of academic impact, for papers by Ricardo J. Gonzalez‐Rothi Breakdown of academic impact, for papers by Kyle A. Weant Breakdown of academic impact, for papers by Odd Brørs Breakdown of academic impact, for papers by Stephen M. Setter Breakdown of academic impact, for papers by Cate Whittlesea Breakdown of academic impact, for papers by Megan A. Rech Breakdown of academic impact, for papers by R. Janknegt Breakdown of academic impact, for papers by Robin Briant Breakdown of academic impact, for papers by Victoria Rollason
Rankless by CCL
2026